Skip to main content

Zentalis Pharmaceuticals, Inc.

ZNTL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001725160

In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Zentalis Pharmaceuticals, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
114
+14 vs. Q1 2026
Shares held
47.4M
+4.10M (+9.5%) vs. Q1 2026
Total value
$228.9M
+$127.9M (+126.6%) vs. Q1 2026
New holders
33
29 more added
Sold out
19
32 more reduced

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ZNTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 114 institutions
Q1 2021: 95 institutionsQ2 2021: 120 institutionsQ3 2021: 116 institutionsQ4 2021: 139 institutionsQ1 2022: 128 institutionsQ2 2022: 122 institutionsQ3 2022: 121 institutionsQ4 2022: 106 institutionsQ1 2023: 110 institutionsQ2 2023: 134 institutionsQ3 2023: 137 institutionsQ4 2023: 120 institutionsQ1 2024: 142 institutionsQ2 2024: 145 institutionsQ3 2024: 136 institutionsQ4 2024: 142 institutionsQ1 2025: 132 institutionsQ2 2025: 117 institutionsQ3 2025: 99 institutionsQ4 2025: 86 institutionsQ1 2026: 102 institutionsQ2 2026: 114 institutions
Value heldQ2 2026: $228.9M
Q1 2021: $1.58BQ2 2021: $2.13BQ3 2021: $2.75BQ4 2021: $3.61BQ1 2022: $2.05BQ2 2022: $1.64BQ3 2022: $1.27BQ4 2022: $1.30BQ1 2023: $1.15BQ2 2023: $2.32BQ3 2023: $1.61BQ4 2023: $1.23BQ1 2024: $1.34BQ2 2024: $314.3MQ3 2024: $261.2MQ4 2024: $195.2MQ1 2025: $92.9MQ2 2025: $64.5MQ3 2025: $79.7MQ4 2025: $54.9MQ1 2026: $101.7MQ2 2026: $228.9M
Institutions holding ZNTL and their total value by quarter
QuarterHoldersValue
Q2 2026114$228.9M
Q1 2026102$101.7M
Q4 202586$54.9M
Q3 202599$79.7M
Q2 2025117$64.5M
Q1 2025132$92.9M
Q4 2024142$195.2M
Q3 2024136$261.2M
Q2 2024145$314.3M
Q1 2024142$1.34B
Q4 2023120$1.23B
Q3 2023137$1.61B
Q2 2023134$2.32B
Q1 2023110$1.15B
Q4 2022106$1.30B
Q3 2022121$1.27B
Q2 2022122$1.64B
Q1 2022128$2.05B
Q4 2021139$3.61B
Q3 2021116$2.75B
Q2 2021120$2.13B
Q1 202195$1.58B

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Zentalis Pharmaceuticals, Inc.; share changes are against Q1 2026.

Institutions holding ZNTL in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
EverSource Wealth Advisors, LLC1,944$9.43K0.00%+245+14.4%Added
Royal Bank of Canada1,636$8.00K0.00%+1,538+1,569.4%Added
Sterling Capital Management LLC1,008$4.89K0.00%+1,008New
Bryn Mawr Trust Co1,000$4.85K0.00%00.0%Unchanged
California State Teachers Retirement System689$3.34K0.00%+689New
Clear Street Markets LLC514$2.49K0.00%+514New
Nisa Investment Advisors, LLC387$1.88K0.00%00.0%Unchanged
Fortitude Family Office, LLC209$1.01K0.00%00.0%Unchanged
HighMark Wealth Management LLC130$6300.00%00.0%Unchanged
Silicon Valley Capital Partners84$4070.00%00.0%Unchanged
Caitong International Asset Management Co., Ltd31$1500.00%+31New
SBI Securities Co., Ltd.27$1310.00%00.0%Unchanged
CWM Advisors, LLC21$1040.00%00.0%Unchanged
Optiver Holding B.V.4$190.00%−40−90.9%Reduced
Almitas Capital LLC0$00.00%−610,073−100.0%Sold out
Woodline Partners LP0$00.00%−266,032−100.0%Sold out
Panagora Asset Management Inc0$00.00%−139,690−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−117,127−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−94,854−100.0%Sold out
49 Wealth Management, LLC0$00.00%−66,401−100.0%Sold out
HRT Financial LP0$00.00%−52,185−100.0%Sold out
Omers Administration Corp0$00.00%−47,700−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−47,063−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−34,849−100.0%Sold out
Headlands Technologies LLC0$00.00%−29,899−100.0%Sold out
AQR Capital Management LLC0$00.00%−22,675−100.0%Sold out
Prudential Financial Inc0$00.00%−20,850−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−20,600−100.0%Sold out
Birchview Capital, LP0$00.00%−17,503−100.0%Sold out
Catalyst Funds Management Pty Ltd0$00.00%−16,700−100.0%Sold out
CTC Alternative Strategies, Ltd.0$00.00%−12,500−100.0%Sold out
Shay Capital LLC0$00.00%−10,662−100.0%Sold out
Group One Trading, L.P.0$00.00%−1,460−100.0%Sold out
Anfield Capital Management, LLC––––Not filed
CWM, LLC––––Not filed